Clinical trial
Predict - a Translational Study to Predict Tumour Response to Neoadjuvant Treatment
NCT04130971 is registered in ClinicalTrials.gov with Sahlgrenska University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predict - a Translational Study to Predict Tumour Response to Neoadjuvant Treatment
- Lead sponsor
- Sahlgrenska University Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 1, 2019
- Completion date
- December 31, 2027
- Enrollment
- 800 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.